CG Oncology, Inc. Common stock
CGON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $257 | $8 | $88 | $54 |
| Short-Term Investments | $485 | $179 | $55 | $0 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $6 | $3 | $5 |
| Total Curr. Assets | $754 | $194 | $147 | $58 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $5 | $0 | $0 |
| Total NC Assets | $1 | $5 | $1 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $755 | $199 | $148 | $59 |
| Liabilities | – | – | – | – |
| Payables | $7 | $3 | $1 | $1 |
| Short-Term Debt | $0 | $1 | $9 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $15 | $10 | $5 | $2 |
| Total Curr. Liab. | $21 | $14 | $15 | $6 |
| LT Debt | $0 | $0 | $7 | $12 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $7 | $12 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $21 | $15 | $23 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $308 | $203 | $83 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$218 | -$130 | -$81 | -$46 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $951 | $7 | $4 | $3 |
| Total Equity | $733 | $185 | $125 | $40 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $755 | $199 | $148 | $59 |
| Net Debt | -$257 | -$7 | -$72 | -$38 |